Equity · Healthcare
IBRX
NASDAQImmunityBio (IBRX)
The line runs 7.74 USD on 12 August through 7.13 USD on 9 November, on a scale from 7 to 11. Days the market did not trade hold the previous close, flat.
- Market cap
- 7.6B USD
- Revenue, year to Dec 2025
- 113.3M USD
- EPS, diluted, year to Dec 2025
- −0.38 USD
- 52-week range
- 1.98 USD – 12 USD
- Avg volume
- 753.8K
- Mentions, 30 days
- 14
- Net sentiment
- +0.13
as of Nov 9, 2026
Have ImmunityBio (IBRX) insiders bought or sold shares recently?
In the 90 days to 10 Nov 2026, ImmunityBio insiders reported 2 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 12 Dec 2025, show no open-market purchase.
Form 4, 90 days to 10 Nov 2026, newest reported trade 5 Oct 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 05 Oct 2026 | Simon Barry J.Director | Sell | 25,000 | 269K USD |
| 02 Oct 2026 | Cohen CherylDirector | Sell | 81,056 | 851K USD |
| Sold | 2 open-market sales | 106,056 | $1.12M |
1 other filing in the window: a grant, exercise, tax withholding or transfer, not a trade
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 02 Oct 2026 | Cohen CherylDirector | Option exercise | 55,979 | 167K USD |
Which funds hold ImmunityBio (IBRX)?
8 of the 45 institutional funds we track reported a ImmunityBio position for the quarter ended 30 Jun 2026 — a combined 263.4M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| D. E. Shaw & Co. | Held (±25%) | 11,551,019 | 101.1M USD | −8.1% |
| Two Sigma Investments | Added | 11,097,106 | 97.2M USD | +153.0% |
| Millennium Management | Added | 5,579,793 | 48.9M USD | +292.9% |
| Renaissance Technologies | New position | 1,029,399 | 9.0M USD | |
| Marshall Wace | Added | 387,700 | 3.4M USD | +403.3% |
| AQR Capital Management | Added | 222,862 | 2.0M USD | +234.9% |
| Citadel Advisors | Trimmed | 136,045 | 1.2M USD | −55.5% |
| Balyasny Asset Management | Held (±25%) | 83,584 | 732K USD | −19.5% |
| Tudor Investment Corp | Exited |
Have members of Congress traded ImmunityBio (IBRX)?
The most recent congressional trade disclosed in ImmunityBio is a purchase by Lisa C. McClain (house, MI), dated 30 Sep 2026.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 30 Sep 2026 | Lisa C. McClainhouse · Republican–MI | Purchase | 1K USD–15K USD | 12 days |
| 28 Sep 2026 | Lisa C. McClainhouse · Republican–MI | Purchase | 1K USD–15K USD | 14 days |
| 06 Mar 2023 | Daniel S. Goldmanhouse · Democrat–NY | Sale | 1K USD–15K USD | 42 days |
What has been filed or recorded for ImmunityBio (IBRX)?
The filings we hold for ImmunityBio, newest first: 10 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 14 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 14 Oct 2026 | Fails to deliver | Shares failed to deliver | 8,401 shares | 82K USD notional · 0.001% of shares out |
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 67,397 shares | 682K USD notional · 0.006% of shares out |
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 5,892 shares | 58K USD notional · 0.001% of shares out |
| 08 Oct 2026 | Fails to deliver | Shares failed to deliver | 2,657 shares | 26K USD notional · <0.001% of shares out |
| 06 Oct 2026 | Fails to deliver | Shares failed to deliver | 2,401 shares | 25K USD notional · <0.001% of shares out |
| 05 Oct 2026 | Fails to deliver | Shares failed to deliver | 296,158 shares | 3.0M USD notional · 0.028% of shares out |
| 02 Oct 2026 | Fails to deliver | Shares failed to deliver | 24,060 shares | 223K USD notional · 0.002% of shares out |
| 01 Oct 2026 | Fails to deliver | Shares failed to deliver | 191,583 shares | 1.8M USD notional · 0.018% of shares out |
| 30 Sep 2026 | Fails to deliver | Shares failed to deliver | 3,076 shares | 27K USD notional · <0.001% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS −0.18 USD | Revenue $49M |
| 30 Sep 2026 | Financials | Total assets | 609.4M USD | at period end |
| 30 Sep 2026 | Financials | Total equity | −1.1B USD | at period end |
| 29 Sep 2026 | Fails to deliver | Shares failed to deliver | 3,069 shares | 26K USD notional · <0.001% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.22 USD | Revenue $51M |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.62 USD | Revenue $44M |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −0.38 USD | Revenue $113M |
| 31 Dec 2025 | Financials | Revenue | 113.3M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −351.4M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −0.38 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −0.07 USD | Revenue $32M |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −0.10 USD | Revenue $26M |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −0.15 USD | Revenue $17M |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −0.62 USD | Revenue $15M |
What is Reddit saying about ImmunityBio (IBRX)?
Reddit mentioned IBRX 14 times in the 30 days to 10 November 2026, across 2 of the communities we track. All of them were scored for sentiment: 57% read bullish, 21% bearish and 22% neither. Reddit data updated 10 November 2026.
30-day window, Method
How do Reddit mentions of ImmunityBio (IBRX) compare with its price?
Share ↗
Which subreddits are talking about ImmunityBio (IBRX)?
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 93% | 13 | +0.13 |
| r/stocks | 7% | 1 | +0.15 |
Which names move with ImmunityBio (IBRX) on Reddit?
Core CPI moved most closely with ImmunityBio (IBRX): when the crowd talked about one, it talked about the other (+0.80 over 31 days). Co-discussion, not price.
Core CPI | ||||||
|---|---|---|---|---|---|---|
IBRX | +0.80 | +0.76 | +0.74 | +0.72 | +0.72 | +0.71 |
View the matrix as a tableHide the table
| Pair | Match | Days measured |
|---|---|---|
| IBRX and Core CPI | +0.80 | 31 days |
| IBRX and VOD | +0.76 | 31 days |
| IBRX and JAAA | +0.74 | 31 days |
| IBRX and BLK | +0.72 | 31 days |
| IBRX and CLF | +0.72 | 31 days |
| IBRX and ASML | +0.71 | 31 days |
What do people ask about ImmunityBio (IBRX)?
What did ImmunityBio shares close at?7.13
ImmunityBio closed at 7.13 USD on 9 Nov 2026, down 17.38% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is ImmunityBio’s market cap?7.6B
ImmunityBio is worth 7.6B USD by market value as of 9 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is ImmunityBio’s revenue?113.3M
ImmunityBio reported revenue of 113.3M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have ImmunityBio insiders bought or sold shares recently?2 sales
In the 90 days to 10 Nov 2026, ImmunityBio insiders reported 2 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 12 Dec 2025, show no open-market purchase. A further 1 filing was a grant, award, gift or exercise rather than an open-market trade. See Insiders
Which funds own ImmunityBio?8 of 45
8 of the 45 funds we track reported a ImmunityBio position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were D. E. Shaw & Co., Two Sigma Investments and Millennium Management. See Funds
Have members of Congress traded ImmunityBio?3 trades
Yes. 3 trades in ImmunityBio appear in the congressional disclosures we hold; the latest is a purchase by Lisa C. McClain (House, MI) dated 30 Sep 2026, filed 12 Oct 2026. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did ImmunityBio last report earnings?−0.18
ImmunityBio last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.18 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about ImmunityBio?1 mentions
ImmunityBio was mentioned 1 times in the last 7 days across the finance subreddits we track, and 14 times over the trailing 30 days. Of the 14 mentions scored for sentiment, 57% read bullish and 21% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- Wikimedia CommonsPortraits via Wikimedia Commons. Lisa C. McClain: Office of Congresswoman Lisa McClain, Public domain; Daniel S. Goldman: US House, Public domain.
- House disclosuresU.S. House of Representatives financial disclosures
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings